Direct β1/ β2 AMPK activation reduces liver steatosis but not fibrosis in a mouse model of non-alcoholic steatohepatitis

Author:

Mather Karly M.ORCID,Boland Michelle L.,Rivers Emma L.ORCID,Srivastava Abhishek,Schimpl MarianneORCID,Hemsley Paul,Robinson James,Wan Paul T.ORCID,Hansen JosefineORCID,Read Jon A.ORCID,Trevaskis James L.ORCID,Smith David M.ORCID

Abstract

Abstract5’AMP-activated protein kinase (AMPK) activators show potential for treating Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) due to their inhibiting effects on fatty acid and cholesterol synthesis. The absence of treatments for NASH, and its propensity for progression to severe disease, lead us to identify and characterize BI9774, a small molecule AMPK activator, which we used to evaluate this potential, including its ability to reduce the NASH specific qualities of fibrosis and inflammation in a preclinical study.MaleLepob/Lepobmice on a control or NASH inducing (AMLN) diet, with liver fibrosis were given BI9774 or vehicle for 6 weeks while metabolic and NASH endpoints were evaluated.BI9774 treatment decreased plasma ALT, terminal liver weight, and liver lipids. RNA expression of collagen-related genes decreased, although collagen protein and inflammation remained unaltered. We also observed increased heart weight and glycogen levels, and increased expression of genes associated with cardiac hypertrophy.AMPK activation improved many metabolic endpoints, but lack of significant improvement in liver fibrosis and negative cardiac effects suggest systemic AMPK activation is not an ideal NASH therapy. Reductions in steatosis and fibrosis-related genes indicate that, with extended treatment, a liver specific AMPK activator has potential to resolve hepatic fibrosis.Summary StatementFatty liver disease affects up to 30 percent of adults worldwide with 30% of patients progressing to more sever liver disease. AMPK activation can help reduce liver fat.

Publisher

Cold Spring Harbor Laboratory

Reference55 articles.

1. Cardiac Ankyrin Repeat Protein Is a Novel Marker of Cardiac Hypertrophy

2. Gene expression analysis of hepatic roles in cause and development of diabetes in Goto-Kakizaki rats

3. AMP-activated Protein Kinase Plays a Role in the Control of Food Intake

4. Boehringer-Ingelheim. 2021 AMPK Activator | BI-9774 [Online]. Available: https://www.opnme.com/molecules/ampk-bi-9774 [Accessed].

5. Bricogne G. B. E. , Brandl M , Flensburg C , Keller P , Paciorek W , et al BUSTER v.2.11.6. ed.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3